Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127503521 | 12750352 | 1 | I | 20160912 | 20160916 | 20160916 | EXP | DE-JNJFOC-20160911626 | JANSSEN | RUDDEL J, SCHLEENVOIGT BT, SCHULER E, SCHMIDT C, PLETZ MW, STALLMACH A. YELLOW FEVER VACCINATION DURING TREATMENT WITH INFLIXIMAB IN A PATIENT WITH ULCERATIVE COLITIS. Z GASTROENTEROL 2016;54:1081-1084. | 59.00 | YR | A | M | Y | 0.00000 | 20160916 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127503521 | 12750352 | 1 | PS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | 103772 | 400 | MG | LYOPHILIZED POWDER |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127503521 | 12750352 | 1 | Colitis ulcerative |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127503521 | 12750352 | HO |
| 127503521 | 12750352 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127503521 | 12750352 | Colitis ulcerative | |
| 127503521 | 12750352 | Contraindication to vaccination | |
| 127503521 | 12750352 | Metabolic syndrome | |
| 127503521 | 12750352 | Non-alcoholic steatohepatitis | |
| 127503521 | 12750352 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |